Clinical Trial

Autologous Decidual-like Natural Killer Cells Therapy for Reproductive Failure

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of this study is to verify the efficacy of in vitro induction of autologous decidual-like NK cells therapy for reproductive failure associated with uterine NK cells abnormalities.
Trial Details
NCT Number NCT07230574
Lead Sponsor The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborators: The University of Science and Technology of China, Sir Run Run Shaw Hospital, Second Affiliated Hospital of Soochow University, The First Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of University of Science and Technology of China
Conditions Abortion, Missed, Infertility Unexplained, Reproductive Disorder
Enrollment 159 participants
Start Date 2025-11
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2025-11-17